SUN PHARMACEUTICAL INDUSTRIES
Back to Cashflow Statement
|
SUN PHARMACEUTICAL INDUSTRIES Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹12,419 Cr | ₹14,072 Cr | ₹12,135 Cr | ₹4,959 Cr | ₹8,985 Cr |
What is the latest Cash Flow from Operating Activities ratio of SUN PHARMACEUTICAL INDUSTRIES ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2026 | ₹12,419 Cr |
| Mar2025 | ₹14,072 Cr |
| Mar2024 | ₹12,135 Cr |
| Mar2023 | ₹4,959 Cr |
| Mar2022 | ₹8,985 Cr |
How is Cash Flow from Operating Activities of SUN PHARMACEUTICAL INDUSTRIES Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹12,419 Cr | -11.75 | |
| Mar2025 | ₹14,072 Cr | 15.96 | |
| Mar2024 | ₹12,135 Cr | 144.69 | |
| Mar2023 | ₹4,959 Cr | -44.80 | |
| Mar2022 | ₹8,985 Cr | - | |
Compare Cash Flow from Operating Activities of peers of SUN PHARMACEUTICAL INDUSTRIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUN PHARMACEUTICAL INDUSTRIES | ₹449,220.9 Cr | -0.8% | 7.3% | 7.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹293,874.0 Cr | -3.3% | 21.8% | 68.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹176,413.0 Cr | -1.7% | 1.9% | 22.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹116,604.0 Cr | 0.7% | 12.4% | 12.4% | Stock Analytics | |
| CIPLA | ₹114,720.0 Cr | 0.7% | 6.7% | -9.4% | Stock Analytics | |
| MANKIND PHARMA | ₹109,040.0 Cr | 0.2% | 17.2% | 15.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUN PHARMACEUTICAL INDUSTRIES | -0.8% |
7.3% |
7.7% |
| SENSEX | 0.2% |
9.8% |
-2.9% |
You may also like the below Video Courses